Skip to content

THERATOPIX PHARMA

Dissolution or liquidation
Public limited companyfounded 2019Rue Louvrex 55-57, 4000 Liège, Belgium52 active companies are registered at this addressKBO/BCE: BE 0738.446.251

From the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette

The KBO register currently lists the legal status of THERATOPIX PHARMA as dissolution or liquidation, with no start date. Dissolved on 23-06-2025, in liquidation; liquidator: Roman AYDOGDU.

Summary

The 2025 annual accounts show negative equity (-€129,765) and a net result of -€18,947.

Follow Report
THERATOPIX PHARMADissolution or liquidation
Report

Overview

Official details

KBO
Status
Active since 26-11-2019 Voluntary dissolution and liquidation
Legal form
Public limited company
Registered office
Rue Louvrex 55-57, 4000 Liège
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21209and 3 others
Establishment unit
2.296.296.737 4031 Liège, since 26-11-2019
Financial year end
31 December
Peppol
Reachable since 09-04-2026
Company details

Who decides

Board
  • PHARMBIOSOLDirector · since 26-11-2019 · permanent representative OLIVIER Sabine
  • ARNAUD ALLAER GESTIONDirector · since 01-02-2023 · permanent representative ALLAER Arnaud Laurent Marc
  • BOURS Vincent Marie Henri NicolasDirector · since 01-02-2023
  • FELLIN Benoît StéphaneDirector · since 01-02-2023
  • NOSHAQ PARTNERSDirector · since 01-02-2023 · permanent representative SABATEL Hélène Catherine Andrée
Shareholders
Board & ownership

How it is doing

Dissolution or liquidation: no score
Annual accounts 2025
Turnover
€49,054
▲ 141%
Loss
€18,947
▼ 95.7%
Equity
-€129,765
▼ 17.1%
Total assets
€120,455
▼ 17.7%
Filed on 16-10-2026at the National Bank
Financials
Signalsraises riskRegister: dissolution or liquidationNegative equity2025 accounts filed 77 days lateShow the evidence

Signals

Three signals.
raises risk
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
20212223242525
2020 to 2025 · latest year -€129,765
raises risk · Register: dissolution or liquidation
The KBO register currently gives the legal situation as dissolution or liquidation, with no start date.
KBO · legal situation
raises risk · 2025 accounts filed 77 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-10-2026, 77 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 7 filings
Deviation from the deadline
2025
77 days late
2025
266 days late
2024
41 days early
2023
47 days early
2022
52 days early
2021
62 days early
2020
64 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 11 days after the deadline; the sector median (NACE 21) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Documents

Annual accounts at the NBB

All 7 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about THERATOPIX PHARMA

What is the company number of THERATOPIX PHARMA?
0738.446.251. In Belgium the VAT number is the company number with BE in front: BE 0738.446.251.
Where was THERATOPIX PHARMA based?
The last known address of the registered office is Rue Louvrex 55-57, 4000 Liège.Company details
What does THERATOPIX PHARMA do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
What is the legal form of THERATOPIX PHARMA?
Public limited company (NV).
When was THERATOPIX PHARMA founded?
On 26-11-2019.
Is THERATOPIX PHARMA still active?
No. According to the KBO register, THERATOPIX PHARMA is dissolved or in liquidation.
How many employees did THERATOPIX PHARMA have?
On average 0.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of THERATOPIX PHARMA?
€49,054 in financial year 2025, according to the filed annual accounts.
Is THERATOPIX PHARMA profitable?
In financial year 2025, THERATOPIX PHARMA made a loss of €18,947.
Where can I find the annual accounts of THERATOPIX PHARMA?
THERATOPIX PHARMA filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank

Companies related to THERATOPIX PHARMA

Go further with this company

What became of the directors' other companies?Supplier due diligence Who ran this company, and where was it based, on a given date before it ended?Company as of a date How is the manufacture of basic pharmaceutical products and pharmaceutical preparations sector doing?Sector figures

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure